Inactive

The NCATS’ Rare Disease Clinical Research Network (RDCRN) wishes to integrate their single sign-on (SSO) solution into the Cavatica Platform. The Cavatica Platform is a commercial data analysis and sh... The NCATS’ Rare Disease Clinical Research Network (RDCRN) wishes to integrate their single sign-on (SSO) solution into the Cavatica Platform. The Cavatica Platform is a commercial data analysis and sharing platform used by researchers to share access to pediatric genomics data. SSO will allow RDCRN users to sign in from their home organization rather than maintain a separate sign-on identify with Cavatica. Cavatica is developed by Seven Bridges and funded in part by grants from the NIH Common Fund. The RDCRN runs Shibboleth IdP, running in a proxy mode relying on logins through InCommon institutions, eRA, and login.gov. RDCRN has full ownership of the identity provider (IdP) and it is fully managed.